Literature DB >> 2869258

Twenty-eight cases of human heart-lung transplantation.

C M Burke, J Theodore, J C Baldwin, H D Tazelaar, A J Morris, C McGregor, N E Shumway, E D Robin, S W Jamieson.   

Abstract

Between March, 1981, and August, 1985, twenty-eight heart-lung transplant operations were done in 27 patients at a single institution. 8 patients died in the perioperative period and adhesions related to previous thoracic surgery proved to be a major risk factor for postoperative haemorrhage. Obliterative bronchiolitis developed in half of the 20 long-term survivors, a mean of 11.2 months (range 2-35 months) after surgery: 4 of these patients died, 3 are functionally limited, 2 were successfully treated with corticosteroids, and the remaining patient was successfully retransplanted. The other 10 long-term survivors returned to a normal life with essentially normal pulmonary function measured at a mean of 22.6 months (range 4-42 months) after transplantation. All the surviving patients have evidence of renal impairment related to cyclosporin nephrotoxicity. The results indicate that, although heart-lung transplantation is compatible with essentially normal long-term pulmonary function, the procedure should not yet be regarded as a routine clinical intervention.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2869258     DOI: 10.1016/s0140-6736(86)90881-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  13 in total

1.  Intensive care management of children following heart and heart-lung transplantation.

Authors:  B Whitehead; I James; P Helms; J P Scott; R Smyth; T W Higenbottam; J McGoldrick; T A English; J Wallwork; M Elliott
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

Review 2.  The current state of lung transplantation.

Authors:  J Dark; P A Corris
Journal:  Thorax       Date:  1989-09       Impact factor: 9.139

Review 3.  Bronchiolitis obliterans following the ingestion of an Asian shrub leaf.

Authors:  T W Higenbottam
Journal:  Thorax       Date:  1997-08       Impact factor: 9.139

Review 4.  Bronchiolitis obliterans with organising pneumonia: outcome.

Authors:  U Costabel; J Guzman; H Teschler
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

5.  Heart and lung transplantation in patients with end stage lung disease.

Authors:  A Penketh; T Higenbottam; M Hakim; J Wallwork
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-01

6.  Clinical experience in the management of pulmonary opportunist infection and rejection in recipients of heart-lung transplants.

Authors:  A R Penketh; T W Higenbottam; J Hutter; C Coutts; S Stewart; J Wallwork
Journal:  Thorax       Date:  1988-10       Impact factor: 9.139

7.  The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease.

Authors:  Xiaoqin Hua; Tobias Deuse; Yi-Je Chen; Heike Wulff; Mandy Stubbendorff; Ralf Köhler; Hiroto Miura; Florian Länger; Hermann Reichenspurner; Robert C Robbins; Sonja Schrepfer
Journal:  Transplantation       Date:  2013-01-27       Impact factor: 4.939

8.  Single- and double-lung transplantation. Problems and possible solutions.

Authors:  S Raju; B J Heath; E T Warren; J D Hardy
Journal:  Ann Surg       Date:  1990-06       Impact factor: 12.969

9.  Primary human adult lung epithelial cells in vitro: response to interferon-gamma and cytomegalovirus.

Authors:  L Ibrahim; M Dominguez; M Yacoub
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

10.  The Nottingham Health Profile as a measure of quality of life following combined heart and lung transplantation.

Authors:  B J O'Brien; N R Banner; S Gibson; M H Yacoub
Journal:  J Epidemiol Community Health       Date:  1988-09       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.